Harvard Bioscience (HBIO) Total Debt (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Total Debt of $36.2 million for Q1 2026, up 0.7% year-over-year from $36.0 million in Q1 2025, and up 0.95% quarter-over-quarter from $35.9 million in Q4 2025.
Harvard Bioscience (HBIO) Total Debt (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Total Debt for 17 consecutive years, with $36.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Debt rose 0.7% year-over-year to $36.2 million; the TTM figure through Mar 2026 stood at $36.2 million (up 0.7% YoY), while the FY2025 annual figure was $35.9 million, down 2.94% from the prior year.
- Total Debt climbed to $36.2 million in Q1 2026 per HBIO's latest filing, from $35.9 million in the prior quarter.
- Across five years, Total Debt topped out at $51.7 million in Q1 2022 and bottomed at $34.0 million in Q3 2025.
- Historically, Total Debt has averaged $41.1 million across 5 years, with a median of $38.7 million in 2023.
- Annual changes were most pronounced in 2022 — Total Debt increased 18.62% — and 2024, when it retreated 24.27%.
- Harvard Bioscience's Total Debt stood at $46.8 million in 2022, then slipped by 9.4% to $42.4 million in 2023, then decreased by 12.88% to $37.0 million in 2024, then retreated by 2.94% to $35.9 million in 2025, then gained by 0.95% to $36.2 million in 2026.
- Business Quant data shows HBIO's Total Debt at $36.2 million in Q1 2026, $35.9 million in Q4 2025, and $34.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 16.81 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 4.72 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 659.37 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 12.58 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 202.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 5.08 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 2.46 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 9.46 Bn |
| 10 | Harvard Bioscience | 34.12 Mn | 27.61 Mn | 12.63 Mn | 36.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 36.68 Mn |
| Mar 31, 2026 | 36.21 Mn |
| Dec 31, 2025 | 35.87 Mn |
| Sep 30, 2025 | 33.97 Mn |
| Jun 30, 2025 | 34.86 Mn |
| Mar 31, 2025 | 35.96 Mn |
| Dec 31, 2024 | 36.96 Mn |
| Sep 30, 2024 | 41.46 Mn |
| Jun 30, 2024 | 35.68 Mn |
| Mar 31, 2024 | 35.61 Mn |
| Dec 31, 2023 | 42.42 Mn |
| Sep 30, 2023 | 38.74 Mn |
| Jun 30, 2023 | 44.64 Mn |
| Mar 31, 2023 | 47.02 Mn |
| Dec 31, 2022 | 46.82 Mn |
| Sep 30, 2022 | 49.25 Mn |
| Jun 30, 2022 | 51.20 Mn |
| Mar 31, 2022 | 51.68 Mn |
| Dec 31, 2021 | 51.57 Mn |
| Sep 30, 2021 | 47.68 Mn |